Find publications by Adaptive as well as our collaborators and partners who leverage our technologies.




Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma

Algazi et al.

  • Clinical Cancer Research
  • June 2020

Immunotherapy of CT26 Murine Tumors Is Characterized by an Oligoclonal Response of Tissue-Resident Memory T Cells Against the AH1 Rejection Antigen

Stringhini et al.

  • European Journal of Immunology
  • May 2020

Deep immune profiling of patients treated with lenalidomide and dexamethasone with or without daratumumab

Casneuf et al.

  • Leukemia
  • May 2020

Genetic and Immune Changes Associated with Disease Progression under the Pressure of Oncolytic Therapy in A Neuroblastoma Outlier Patient

Franco-Luzon et al.

  • Cancers
  • April 2020

Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer

Phillips et al.

  • JAMA Oncology
  • March 2020

Peripheral T cell expansion predicts tumour infiltration and clinical response

Wu et al.

  • Nature
  • February 2020

Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas

Aslan et al.

  • Nature Communications
  • February 2020

Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R- Dependent STING Activation by Tumor-Derived cGAMP

Zhou et al.

  • Immunity
  • February 2020

Immune awakening revealed by peripheral T cell dynamics after one cycle of immunotherapy

Valpione et al.

  • Nature Cancer
  • February 2020